A prospective population-based study of triggers of symptomatic flares in IBD.

PubWeight™: 1.72‹?› | Rank: Top 3%

🔗 View Article (PMID 20372115)

Published in Am J Gastroenterol on April 06, 2010

Authors

Charles N Bernstein1, Sunny Singh, Lesley A Graff, John R Walker, Norine Miller, Mary Cheang

Author Affiliations

1: IBD Clinical and Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada. cbernst@cc.umanitoba.ca

Associated clinical trials:

Somatosensory Profiles in Individuals With Persistent Musculoskeletal Pain and Inflammatory Bowel Disease | NCT03799471

Assessing the Effectiveness of a Stress Reduction Intervention in Inflammatory Bowel Disease (IBD) | NCT03831750

Articles citing this

The Relationship Among Perceived Stress, Symptoms, and Inflammation in Persons With Inflammatory Bowel Disease. Am J Gastroenterol (2015) 2.51

Role of Nonsteroidal Anti-Inflammatory Drugs in Exacerbations of Inflammatory Bowel Disease. J Clin Gastroenterol (2016) 1.47

Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort study. Ann Intern Med (2012) 1.44

Environmental factors in the relapse and recurrence of inflammatory bowel disease: a review of the literature. Dig Dis Sci (2014) 1.41

A clinical review of recent findings in the epidemiology of inflammatory bowel disease. Clin Epidemiol (2013) 1.40

Inflammation drives dysbiosis and bacterial invasion in murine models of ileal Crohn's disease. PLoS One (2012) 1.28

Environmental triggers for inflammatory bowel disease. Curr Gastroenterol Rep (2013) 1.26

Psychological issues in inflammatory bowel disease: an overview. Gastroenterol Res Pract (2012) 1.16

Gastrointestinal and psychological mediators of health-related quality of life in IBS and IBD: a structural equation modeling analysis. Am J Gastroenterol (2011) 1.09

Environment and the inflammatory bowel diseases. Can J Gastroenterol (2013) 1.07

Treatment of IBD: where we are and where we are going. Am J Gastroenterol (2014) 1.02

Exposure to a social stressor disrupts the community structure of the colonic mucosa-associated microbiota. BMC Microbiol (2014) 0.97

Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis. Aliment Pharmacol Ther (2013) 0.94

Life-event stress induced by the Great East Japan Earthquake was associated with relapse in ulcerative colitis but not Crohn's disease: a retrospective cohort study. BMJ Open (2013) 0.94

Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol (N Y) (2013) 0.93

Environmental risk factors for inflammatory bowel diseases: a review. Dig Dis Sci (2014) 0.92

Gut Bacterial DNA Translocation is an Independent Risk Factor of Flare at Short Term in Patients With Crohn's Disease. Am J Gastroenterol (2016) 0.90

Behavioral interventions may prolong remission in patients with inflammatory bowel disease. Behav Res Ther (2010) 0.89

Dissecting the Interplay Between Intestinal Microbiota and Host Immunity in Health and Disease: Lessons Learned from Germfree and Gnotobiotic Animal Models. Eur J Microbiol Immunol (Bp) (2016) 0.88

Impact of stressor exposure on the interplay between commensal microbiota and host inflammation. Gut Microbes (2014) 0.87

Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease. World J Gastroenterol (2014) 0.84

The structures of the colonic mucosa-associated and luminal microbial communities are distinct and differentially affected by a prolonged murine stressor. Gut Microbes (2014) 0.83

Challenges in designing a national surveillance program for inflammatory bowel disease in the United States. Inflamm Bowel Dis (2014) 0.83

Cognitive-behavioural therapy has no effect on disease activity but improves quality of life in subgroups of patients with inflammatory bowel disease: a pilot randomised controlled trial. BMC Gastroenterol (2015) 0.83

Assessing the Relationship between Sources of Stress and Symptom Changes among Persons with IBD over Time: A Prospective Study. Can J Gastroenterol Hepatol (2016) 0.82

Risk Factors for Rehospitalization Within 90 Days in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis (2015) 0.82

Irritable bowel syndrome and inflammatory bowel disease overlap syndrome: pieces of the puzzle are falling into place. Intest Res (2016) 0.82

The epidemiology and risk factors of inflammatory bowel disease. Int J Clin Exp Med (2015) 0.82

Association of Inflammatory Bowel Disease (IBD) with Depressive Symptoms in the United States Population and Independent Predictors of Depressive Symptoms in an IBD Population: A NHANES Study. Gut Liver (2017) 0.81

Case-control study of factors that trigger inflammatory bowel disease flares. World J Gastroenterol (2014) 0.81

Functional magnetic resonance imaging study reveals differences in the habituation to psychological stress in patients with Crohn's disease versus healthy controls. J Behav Med (2012) 0.81

A magic pill? A qualitative analysis of patients' views on the role of antidepressant therapy in inflammatory bowel disease (IBD). BMC Gastroenterol (2012) 0.80

Mechanisms by which Stress Affects the Experimental and Clinical Inflammatory Bowel Disease (IBD): Role of Brain-Gut Axis. Curr Neuropharmacol (2016) 0.80

Environmental influences on the onset and clinical course of Crohn's disease-part 1: an overview of external risk factors. Gastroenterol Hepatol (N Y) (2013) 0.80

Influence of environmental factors in the development of inflammatory bowel diseases. World J Gastrointest Pharmacol Ther (2016) 0.80

Social stress-enhanced severity of Citrobacter rodentium-induced colitis is CCL2-dependent and attenuated by probiotic Lactobacillus reuteri. Mucosal Immunol (2015) 0.80

Dietary ganglioside reduces proinflammatory signaling in the intestine. J Nutr Metab (2012) 0.79

IBS and IBD - separate entities or on a spectrum? Nat Rev Gastroenterol Hepatol (2016) 0.79

High C-Reactive Protein Is Associated with Poor Sleep Quality Independent of Nocturnal Symptoms in Patients with Inflammatory Bowel Disease. Dig Dis Sci (2015) 0.79

Chronic subordinate colony housing paradigm: a mouse model to characterize the consequences of insufficient glucocorticoid signaling. Front Psychiatry (2015) 0.78

Chronic Psychological Stress Disrupted the Composition of the Murine Colonic Microbiota and Accelerated a Murine Model of Inflammatory Bowel Disease. PLoS One (2016) 0.78

Effectiveness of disease-specific cognitive-behavioural therapy on depression, anxiety, quality of life and the clinical course of disease in adolescents with inflammatory bowel disease: study protocol of a multicentre randomised controlled trial (HAPPY-IBD). BMJ Open Gastroenterol (2016) 0.78

A systematic review of disease-related stigmatization in patients living with inflammatory bowel disease. Clin Exp Gastroenterol (2016) 0.78

The commensal microbiota exacerbate infectious colitis in stressor-exposed mice. Brain Behav Immun (2016) 0.77

Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: A double-blind controlled study. J Res Med Sci (2015) 0.77

Prevalence of mental health disorders in inflammatory bowel disease: an Australian outpatient cohort. Clin Exp Gastroenterol (2015) 0.77

Managing pain in inflammatory bowel disease. Gastroenterol Hepatol (N Y) (2011) 0.77

Psychosocial issues in evidence-based guidelines on inflammatory bowel diseases: a review. World J Gastroenterol (2014) 0.76

IBD: Stress causes flares of IBD--how much evidence is enough? Nat Rev Gastroenterol Hepatol (2011) 0.76

Indomethacin-induced translocation of bacteria across enteric epithelia is reactive oxygen species-dependent and reduced by vitamin C. Am J Physiol Gastrointest Liver Physiol (2012) 0.76

Environmental risk factors for inflammatory bowel diseases: Evidence based literature review. World J Gastroenterol (2016) 0.76

Job strain and the risk of inflammatory bowel diseases: individual-participant meta-analysis of 95,000 men and women. PLoS One (2014) 0.76

Development and Application of a Plant-Based Diet Scoring System for Japanese Patients with Inflammatory Bowel Disease. Perm J (2016) 0.75

Integrative Therapies and Pediatric Inflammatory Bowel Disease: The Current Evidence. Children (Basel) (2014) 0.75

Inflammatory bowel disease and anxiety: links, risks, and challenges faced. Clin Exp Gastroenterol (2015) 0.75

Influence of environmental factors on the onset and course of inflammatory bowel disease. World J Gastroenterol (2016) 0.75

Cognitive-Behavioural Therapy for Inflammatory Bowel Disease: 24-Month Data from a Randomised Controlled Trial. Int J Behav Med (2017) 0.75

Vedolizumab Therapy Is Associated with an Improvement in Sleep Quality and Mood in Inflammatory Bowel Diseases. Dig Dis Sci (2016) 0.75

Stressor exposure has prolonged effects on colonic microbial community structure in Citrobacter rodentium-challenged mice. Sci Rep (2017) 0.75

Sleep disturbances in Japanese patients with inflammatory bowel disease and their impact on disease flare. Springerplus (2016) 0.75

The mucosal immune system: master regulator of bidirectional gut-brain communications. Nat Rev Gastroenterol Hepatol (2017) 0.75

Stress as a Trigger for Relapses in IBD: A Case-Crossover Study. Gastroenterology Res (2013) 0.75

The role of the commensal microbiota in adaptive and maladaptive stressor-induced immunomodulation. Horm Behav (2016) 0.75

Efficacy of the Autoimmune Protocol Diet for Inflammatory Bowel Disease. Inflamm Bowel Dis (2017) 0.75

Articles by these authors

A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A (2004) 44.81

Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci U S A (2002) 25.47

Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med (2006) 23.62

Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science (2010) 5.50

Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. N Engl J Med (2002) 4.09

Expression analysis of G Protein-Coupled Receptors in mouse macrophages. Immunome Res (2008) 3.54

Structural basis for recognition of hemi-methylated DNA by the SRA domain of human UHRF1. Nature (2008) 3.39

Activity of IPI-504, a novel heat-shock protein 90 inhibitor, in patients with molecularly defined non-small-cell lung cancer. J Clin Oncol (2010) 3.15

The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proc Natl Acad Sci U S A (2008) 3.13

Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery. Science (2011) 3.07

Circadian and CLOCK-controlled regulation of the mouse transcriptome and cell proliferation. Proc Natl Acad Sci U S A (2007) 3.06

In situ proteolysis for protein crystallization and structure determination. Nat Methods (2007) 3.05

A population-based case control study of potential risk factors for IBD. Am J Gastroenterol (2006) 2.91

Illumination of the melanopsin signaling pathway. Science (2005) 2.58

A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy. Nat Commun (2010) 2.49

Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol (2007) 2.46

SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis. Antimicrob Agents Chemother (2012) 2.41

Pulmonary artery occlusion pressure and central venous pressure fail to predict ventricular filling volume, cardiac performance, or the response to volume infusion in normal subjects. Crit Care Med (2004) 2.35

Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant (2004) 2.35

Gene set enrichment in eQTL data identifies novel annotations and pathway regulators. PLoS Genet (2008) 2.32

Information needs and preferences of recently diagnosed patients with inflammatory bowel disease. Inflamm Bowel Dis (2011) 2.31

Stress coping, distress, and health perceptions in inflammatory bowel disease and community controls. Am J Gastroenterol (2009) 2.22

Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis. Nat Med (2013) 2.19

Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm Bowel Dis (2009) 2.15

Identification of the circadian transcriptome in adult mouse skeletal muscle. Physiol Genomics (2007) 2.06

Validity of a prescription claims database to estimate medication adherence in older persons. Med Care (2006) 2.06

Do NSAIDs, antibiotics, infections, or stress trigger flares in IBD? Am J Gastroenterol (2009) 2.05

Genomewide association analysis in diverse inbred mice: power and population structure. Genetics (2007) 2.01

Vitamin D status and bone density in recently diagnosed inflammatory bowel disease: the Manitoba IBD Cohort Study. Am J Gastroenterol (2008) 1.92

Plasmodium circumsporozoite protein promotes the development of the liver stages of the parasite. Cell (2007) 1.90

Architecture of Eph receptor clusters. Proc Natl Acad Sci U S A (2010) 1.82

Recognition of multivalent histone states associated with heterochromatin by UHRF1 protein. J Biol Chem (2011) 1.79

Whole-genome sequencing and microarray analysis of ex vivo Plasmodium vivax reveal selective pressure on putative drug resistance genes. Proc Natl Acad Sci U S A (2010) 1.74

The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am J Gastroenterol (2008) 1.72

Variable ventilation improves perioperative lung function in patients undergoing abdominal aortic aneurysmectomy. Anesthesiology (2004) 1.65

Extinction training regulates neuroadaptive responses to withdrawal from chronic cocaine self-administration. Learn Mem (2004) 1.63

CLOCK and BMAL1 regulate MyoD and are necessary for maintenance of skeletal muscle phenotype and function. Proc Natl Acad Sci U S A (2010) 1.63

Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozole. Pharmacogenet Genomics (2007) 1.60

Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort. J Rheumatol (2002) 1.59

Amino-terminal dimerization, NRDP1-rhodanese interaction, and inhibited catalytic domain conformation of the ubiquitin-specific protease 8 (USP8). J Biol Chem (2006) 1.59

Effect of large volume infusion on left ventricular volumes, performance and contractility parameters in normal volunteers. Intensive Care Med (2004) 1.59

Mitotic evolution of Plasmodium falciparum shows a stable core genome but recombination in antigen families. PLoS Genet (2013) 1.54

The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life. Clin Gastroenterol Hepatol (2006) 1.52

Identification of a small molecule with activity against drug-resistant and persistent tuberculosis. Proc Natl Acad Sci U S A (2013) 1.51

Multidisciplinary treatment of diabetic foot ulcers in Canadian Aboriginal and non-Aboriginal people. Foot Ankle Surg (2007) 1.46

Familial seropositive rheumatoid arthritis in North American Native families: effects of shared epitope and cytokine genotypes. J Rheumatol (2005) 1.44

A genomic screen for activators of the antioxidant response element. Proc Natl Acad Sci U S A (2007) 1.44

Characterization of stanniocalcin 2, a novel target of the mammalian unfolded protein response with cytoprotective properties. Mol Cell Biol (2004) 1.44

A strategy for modulation of enzymes in the ubiquitin system. Science (2013) 1.43

Type 2 diabetes mellitus in children: prenatal and early infancy risk factors among native canadians. Arch Pediatr Adolesc Med (2002) 1.41

Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry (2014) 1.39

Does elimination of placebo responders in a placebo run-in increase the treatment effect in randomized clinical trials? A meta-analytic evaluation. Depress Anxiety (2004) 1.38

Regulation and recognition of SCFGrr1 targets in the glucose and amino acid signaling pathways. Mol Cell Biol (2004) 1.34

A population-based study of fatigue and sleep difficulties in inflammatory bowel disease. Inflamm Bowel Dis (2010) 1.32

Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease. Inflamm Bowel Dis (2008) 1.30

Discovery and structural analysis of Eph receptor tyrosine kinase inhibitors. Bioorg Med Chem Lett (2009) 1.26

A human ubiquitin conjugating enzyme (E2)-HECT E3 ligase structure-function screen. Mol Cell Proteomics (2012) 1.25

Combination therapy targeting both tumor-initiating and differentiated cell populations in prostate carcinoma. Clin Cancer Res (2010) 1.25

Health risk behaviors and mental health problems as mediators of the relationship between childhood abuse and adult health. Am J Public Health (2008) 1.25

Autoregulation by the juxtamembrane region of the human ephrin receptor tyrosine kinase A3 (EphA3). Structure (2008) 1.23

Separate and cumulative effects of adverse childhood experiences in predicting adult health and health care utilization. Child Abuse Negl (2010) 1.23

Glyoxylate and pyruvate are antagonistic effectors of the Escherichia coli IclR transcriptional regulator. J Biol Chem (2007) 1.22

Efficacy and immunogenicity of Mycobacterium bovis DeltaRD1 against aerosol M. bovis infection in neonatal calves. Vaccine (2009) 1.22

The replication focus targeting sequence (RFTS) domain is a DNA-competitive inhibitor of Dnmt1. J Biol Chem (2011) 1.22

Categorically distinct acute stressors elicit dissimilar transcriptional profiles in the paraventricular nucleus of the hypothalamus. J Neurosci (2003) 1.20

Antituberculosis thiophenes define a requirement for Pks13 in mycolic acid biosynthesis. Nat Chem Biol (2013) 1.20

A novel approach to investigate tissue-specific trinucleotide repeat instability. BMC Syst Biol (2010) 1.20

Identification of small-molecule inducers of pancreatic beta-cell expansion. Proc Natl Acad Sci U S A (2009) 1.20

A functional genomics approach to the mode of action of apratoxin A. Nat Chem Biol (2006) 1.20

Structural and biochemical characterization of the human cyclophilin family of peptidyl-prolyl isomerases. PLoS Biol (2010) 1.18

An RNAi screen identifies TRRAP as a regulator of brain tumor-initiating cell differentiation. Cell Stem Cell (2010) 1.17

Treatment of AIDS-associated Kaposi's sarcoma in Zimbabwe: results of a randomized quality of life focused clinical trial. Int J Cancer (2005) 1.17

The Manitoba IBD Index: evidence for a new and simple indicator of IBD activity. Am J Gastroenterol (2009) 1.15

Gene expression profiles differentiating between breast cancers clinically responsive or resistant to letrozole. J Clin Oncol (2009) 1.14

A small molecule accelerates neuronal differentiation in the adult rat. Proc Natl Acad Sci U S A (2010) 1.12

para-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosis. J Biol Chem (2013) 1.11

Early prognosis of the development of renal chronic allograft rejection by gene expression profiling of human protocol biopsies. Transplantation (2003) 1.11

Early predictors of longterm outcome in patients with juvenile rheumatoid arthritis: subset-specific correlations. J Rheumatol (2003) 1.10

Etiology and determinants of sexually transmitted infections in Karnataka state, south India. Sex Transm Dis (2010) 1.09

Crystal structure of the human ubiquitin-activating enzyme 5 (UBA5) bound to ATP: mechanistic insights into a minimalistic E1 enzyme. J Biol Chem (2010) 1.08

Structure and function of sedoheptulose-7-phosphate isomerase, a critical enzyme for lipopolysaccharide biosynthesis and a target for antibiotic adjuvants. J Biol Chem (2007) 1.07

A conserved mechanism of autoinhibition for the AMPK kinase domain: ATP-binding site and catalytic loop refolding as a means of regulation. Acta Crystallogr Sect F Struct Biol Cryst Commun (2010) 1.05

Structural insights into the inhibited states of the Mer receptor tyrosine kinase. J Struct Biol (2008) 1.04

Identification of homeodomain proteins, PBX1 and PREP1, involved in the transcription of murine leukemia virus. Mol Cell Biol (2003) 1.02

Striatal function in generalized social phobia: a functional magnetic resonance imaging study. Biol Psychiatry (2006) 1.02

Immunogenetic risks of anti-cyclical citrullinated peptide antibodies in a North American Native population with rheumatoid arthritis and their first-degree relatives. J Rheumatol (2009) 1.01

The crystal structures of human calpains 1 and 9 imply diverse mechanisms of action and auto-inhibition. J Mol Biol (2006) 1.01

The Manitoba Inflammatory Bowel Disease Cohort Study: a prospective longitudinal evaluation of the use of complementary and alternative medicine services and products. Gut (2011) 1.01

The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome? Clin Gastroenterol Hepatol (2006) 1.00